KATIE KELLER: Open Payments
NPI 1356812879 · HOBART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,917 in 71 payments from 19 companies in 2025. Trend: 2023 $1,854 · 2024 $1,980 · 2025 $1,917
Food & beverage: $1,917
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 2 | $479 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 17 | $240 |
| Novartis Pharmaceuticals Corporation | 13 | $222 |
| E.R. Squibb & Sons, L.L.C. | 9 | $195 |
| AstraZeneca Pharmaceuticals LP | 3 | $141 |
| Boston Scientific Corporation | 3 | $118 |
| Novo Nordisk Inc | 4 | $97 |
| PFIZER INC. | 5 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $60 |
| Merck Sharp & Dohme LLC | 2 | $43 |
Products named: Rapiblyk, LifeVest, LEQVIO, CAMZYOS, WATCHMAN FLX, FARXIGA, VYNDAQEL, Wegovy.
Industry payments across IN — which companies pay providers there.
